Trial Profile
A Single Site, Randomized Open Label Cross-Over Study to Compare Pharmacokinetic Profiles (PK) of XueZhiKang (XZK) Capsules Versus Lovastatin Tablets in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Apr 2016
Price :
$35
*
At a glance
- Drugs Monascus (Primary) ; Lovastatin
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Luye Pharma Group
- 31 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 17 Nov 2015 New trial record